Arca
Skip to content
Tools
Tools

Eclipse Treatment Planning System

System, Planning, Radiation Therapy Treatment. 510(k) K073020, from Varian Medical Systems, Inc. (Palo Alto, CA). Product code MUJ, class 2.

As of Nov 19, 2026, K073020 is an FDA 510(k) held by Varian Medical Systems, Inc., substantially equivalent on Dec 19, 2007 after 54 days, with 6 recalls tied to it in FDA's recall database.

  • Review time: 54 days
  • Recalls: 6
  • Cited as a predicate by: 3 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The Eclipse Treatment Planning System (Eclipse TPS) is used to plan radiotherapy treatments for patients with malignant or benign diseases. Eclipse TPS is used to plan external beam irradiation with photon, electron and proton beams, as well as for internal irradiation (brachytherapy) treatments.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

3 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K073020, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
Jul 7, 2011Z-3022-2011An anomaly has been identified in the 4D Structure Merge option of certain versions of Varian's Eclipse Treatment Planning System. The treatment field energy may change from the current selection to a previous selection…Terminated
Jun 30, 2011Z-3002-2011In affected Eclipse versions, the treatment field energy may change from the current selection to a previous selection without use intervention and without invalidating the MU or calculated dose distribution.Terminated
May 13, 2011Z-2780-2011In affected Eclipse versions, user editing of the MLC Leaf positions may not automatically invalidate calculated dose distributions.Terminated
May 3, 2011Z-2702-2011In affected Analytical Anisotropy Algorithm versions when modeling the second source, the collimator jaw positions are read from the first control point of the field. This can cause the delivered dose to be higher than…Terminated
Apr 4, 2011Z-2220-2011An anomaly in Eclipse Treatment Planning System, versions 8.0 to 8.6, whereby Actual SSD (source surface distance) value may not correspond to the Planned SSD value after Planning Approval.Terminated
Dec 9, 2009Z-1412-2010Potential for misdelivery of treatment-- When preparing a treatment plan involving a split, the device may calculate excessive or insufficient monitor units for the treatment plan.Terminated

Other MUJ clearances

The newest 510(k)s for the same product code; their median review was 237 days; see every MUJ device

Record

Type
Special
Received
Oct 26, 2007
Review panel
Radiology
Regulation
21 CFR 892.5050

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.